TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1
Scientific Reports · 2024
DOI: 10.1038/s41598-024-77933-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Xingnan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Central Nervous System Injury, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: CDC2 Protein Kinase, Receptors, GABA, Cell Proliferation, Cell Movement. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Platform Construction of Basic Research and Clinical Translation of Nervous System Injury.
Abstract (Originalsprache)
Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell-derived sarcomas that are sporadic or associated with Neurofibromatosis 1 (NF1) gene mutations. Traditional therapies are usually ineffective for treating MPNSTs, so new targets need to be identified for the treatment of MPNSTs. In the present study, the role of the mitochondrial translocator protein (TSPO) in the regulation of cell proliferation and the cell cycle in MPNSTs was investigated. TSPO expression was lower in MPNSTs than in NFs. Loss-of-function experiments revealed that TSPO deficiency promoted MPNST cell growth, migration, and invasion and influenced the cell cycle in vitro and in vivo. In addition, TSPO depletion suppressed cell apoptosis by downregulating the expression of caspase-3, caspase-8, HSP60, p27, p53, and BCL-2 and suppressed the cell cycle by upregulating CDK1, CDK2, CCNB1 and CCNA2. Furthermore, CDK1 was determined to be an upstream target of TSPO-mediated regulation via RNA-seq, qPCR, and Western blotting. Specifically, depletion of CDK1 weakened the effect of TSPO deficiency on cell proliferation and migration. More importantly, CDK1 knockdown induced significant cell cycle arrest in the G2/M phase. In summary, TSPO deficiency regulates the cell cycle in MPNSTs by targeting CDK1, which may be an effective molecular target for prognosis evaluation and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Central Nervous System Injury, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Beijing Key Laboratory of Central Nervous System Injury, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. dr_songliu2018@163.com.
- U1195, Inserm et Universite Paris-Saclay, Le Kremlin-Bicetre, 94276, France. dr_songliu2018@163.com.
Förderung
- National Natural Science Foundation of China
- Platform Construction of Basic Research and Clinical Translation of Nervous System Injury
Zitieren
APA
Zhang, X., Hu, C., Sun, S., Guo, C., Bu, Y., Wang, Z., Liu, Z., Zhang, X., Li, D., & Liu, S. (2024). TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1. Scientific Reports. https://doi.org/10.1038/s41598-024-77933-2
Vancouver
Zhang X, Hu C, Sun S, Guo C, Bu Y, Wang Z, et al. TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1. Scientific Reports. 2024. doi:10.1038/s41598-024-77933-2
BibTeX
@article{Zhang2024,
author = {Zhang, Xingnan and Hu, Chenhao and Sun, Shengqiao and Guo, Chao and Bu, Yakun and Wang, Zicong and Liu, Zewei and Zhang, Xiaoli and Li, Dezhi and Liu, Song},
title = {TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-77933-2}
}
EUVIMED